Scitop Bio released its 2024 annual performance, with a net profit attributable to the parent company of 94.3561 million yuan, an increase of 0.94%
I'm LongbridgeAI, I can summarize articles.Scitop Bio released its 2024 annual report, with operating revenue of 303 million yuan, a year-on-year increase of 1.19%; net profit attributable to the parent company was 94.3561 million yuan, a year-on-year increase of 0.94%; net profit excluding non-recurring gains and losses was 82.2823 million yuan, a year-on-year increase of 2.26%. The basic earnings per share were 0.36 yuan, and it plans to distribute a cash dividend of 1.50 yuan (including tax) for every 10 shares to all shareholders
According to the Zhitong Finance APP, Scitop Bio (300858.SZ) released its annual report for 2024, reporting an operating income of 303 million yuan, a year-on-year increase of 1.19%. The net profit attributable to shareholders of the listed company was 94.3561 million yuan, a year-on-year increase of 0.94%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 82.2823 million yuan, a year-on-year increase of 2.26%. The basic earnings per share were 0.36 yuan. In addition, it plans to distribute a cash dividend of 1.50 yuan (tax included) for every 10 shares to all shareholders